Cystic fibrosis: Pathology review

403,202views

Cystic fibrosis: Pathology review

G3n3tics to add

G3n3tics to add

Legg-Calve-Perthes disease
1p36 deletion syndrome: Year of the Zebra
Cleidocranial dysplasia
Developmental dysplasia of the hip: Clinical sciences
Collagen disorders: Pathology review
Approach to connective tissue disorders: Clinical sciences
Fetal alcohol syndrome
Rett syndrome
Approach to a child with Down syndrome (trisomy 21): Clinical sciences
Approach to aneuploidies and microdeletions: Clinical sciences
Approach to inborn errors of metabolism (acute): Clinical sciences
Approach to inborn errors of metabolism (progressive or chronic): Clinical sciences
Approach to neurocutaneous syndromes: Clinical sciences
Approach to prenatal teratogen exposure: Clinical sciences
Approach to primary immunodeficiencies: Clinical sciences
Cystic fibrosis and primary ciliary dyskinesia: Clinical sciences
Sickle cell disease: Clinical sciences
Developmental milestones (newborn and infant): Clinical sciences
Developmental milestones (toddler): Clinical sciences
Developmental milestones (childhood): Clinical sciences
Approach to atypical genitalia: Clinical sciences
Approach to delay or regression in developmental milestones: Clinical sciences
Approach to delayed puberty: Clinical sciences
Approach to feeding and eating disorders: Clinical sciences
Approach to growth faltering: Clinical sciences
Approach to hypotonia (newborn and infant): Clinical sciences
Approach to neurodevelopmental disorders: Clinical sciences
Approach to poor feeding (newborn and infant): Clinical sciences
Approach to precocious puberty: Clinical sciences
Approach to primary amenorrhea: Clinical sciences
Approach to short stature: Clinical sciences
Obesity (pediatrics): Clinical sciences
Congenital cytomegalovirus (NORD)
Chiari malformation
Seizures and epilepsy
Approach to epilepsy: Clinical sciences
Febrile seizure (pediatrics): Clinical sciences
Early infantile epileptic encephalopathy (NORD)
Spinocerebellar ataxia (NORD)
Sturge-Weber syndrome
Spina bifida
Von Hippel-Lindau disease: Year of the Zebra 2024
Neurocutaneous disorders: Pathology review
Human development days 1-4
Human development days 4-7
Human development week 2
Human development week 3
Development of the digestive system and body cavities
Development of the fetal membranes
Development of the placenta
Development of the umbilical cord
Development of twins
Hedgehog signaling pathway
Ectoderm
Endoderm
Mesoderm
Development of the cardiovascular system
Fetal circulation
Development of the eye
Development of the gastrointestinal system
Development of the teeth
Development of the tongue
Development of the axial skeleton
Development of the limbs
Development of the muscular system
Development of the renal system
Development of the reproductive system
Development of the respiratory system
Peutz-Jeghers syndrome
Autism spectrum disorder
Autism spectrum disorder: Clinical sciences
Developmental and learning disorders: Pathology review
Learning disability
von Hippel-Lindau disease
Muscular dystrophies and mitochondrial myopathies: Pathology review
Fatty acid oxidation
Fatty acid synthesis
Classical homocystinuria (NORD)
Homocystinuria
Alkaptonuria
Cystinuria (NORD)
Hartnup disease
Maple syrup urine disease
Ornithine transcarbamylase deficiency
Phenylketonuria (NORD)
Essential fructosuria
Galactosemia
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Hereditary fructose intolerance
Lactose intolerance
Pyruvate dehydrogenase deficiency
Abetalipoproteinemia
Familial hypercholesterolemia
Hyperlipidemia
Hypertriglyceridemia
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Glycogen storage disease type III
Glycogen storage disease type IV
Glycogen storage disease type V
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Fabry disease (NORD)
Gaucher disease (NORD)
Krabbe disease
Leukodystrophy
Metachromatic leukodystrophy (NORD)
Niemann-Pick disease type C
Niemann-Pick disease types A and B (NORD)
Tay-Sachs disease (NORD)
Cystinosis
Disorders of amino acid metabolism: Pathology review
Disorders of carbohydrate metabolism: Pathology review
Disorders of fatty acid metabolism: Pathology review
Dyslipidemias: Pathology review
Glycogen storage disorders: Pathology review
Lysosomal storage disorders: Pathology review
Hypothyroidism: Pathology review
Hypothyroidism
Approach to hypothyroidism: Clinical sciences
Hypothyroidism medications
Hyperthyroidism medications
Approach to hyperthyroidism and thyrotoxicosis: Clinical sciences
Hyperthyroidism
Hyperthyroidism: Pathology review
Hashimoto thyroiditis: Clinical sciences
Thyroid nodules: Clinical sciences
Multiple endocrine neoplasia: Pathology review
Disorders of sex chromosomes: Pathology review
Disorders of sexual development and sex hormones: Pathology review
Hypopituitarism: Pathology review
Growth hormone deficiency
Congenital adrenal hyperplasia
Atrial septal defect
Coarctation of the aorta
Patent ductus arteriosus
Ventricular septal defect
Hypoplastic left heart syndrome
Tetralogy of Fallot
Total anomalous pulmonary venous return
Transposition of the great vessels
Persistent truncus arteriosus
Cyanotic congenital heart defects: Pathology review
Acyanotic congenital heart defects: Pathology review
Congenital renal disorders: Pathology review
Congenital gastrointestinal disorders: Pathology review
Congenital neurological disorders: Pathology review
Congenital TORCH infections: Pathology review
Approach to congenital heart diseases (cyanotic): Clinical sciences
Approach to congenital heart diseases (acyanotic): Clinical sciences
Introduction to the immune system
MHC class I and MHC class II molecules
VDJ rearrangement
Antibody classes
Ataxia-telangiectasia
DiGeorge syndrome
Wiskott-Aldrich syndrome
X-linked agammaglobulinemia
Selective immunoglobulin A deficiency
Isolated primary immunoglobulin M deficiency
Adenosine deaminase deficiency
Hyper IgM syndrome
Complement deficiency
Chronic granulomatous disease
Leukocyte adhesion deficiency
Thymic aplasia
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Cornelia de Lange syndrome: Year of the Zebra
Alagille syndrome (NORD): Year of the Zebra
Alkaptonuria: Year of the Zebra
Alpha-1 antitrypsin deficiency: Year of the Zebra 2024
Chopra-Amiel-Gordon syndrome: Year of the Zebra 2024
FOXG1 syndrome: Year of the Zebra
Gaucher disease (NORD): Year of the Zebra
Gorlin syndrome: Year of the Zebra
Leprosy: Year of the Zebra
Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: Year of the Zebra
Nail-patella syndrome: Year of the Zebra
PGAP3-congenital disorder of glycosylation: Year of the Zebra
Phenylketonuria (NORD): Year of the Zebra
Pierre Robin sequence: Year of the Zebra
Retroperitoneal fibrosis: Year of the Zebra
Sanfilippo syndrome: Year of the Zebra
Shwachman-Diamond syndrome: Year of the Zebra
Turner syndrome: Year of the Zebra
Andersen-Tawil syndrome: Year of the Zebra 2025
Peroxisomal disorders: Pathology review
Cytoskeleton and elastin disorders: Pathology review
Epidermolysis bullosa: Year of the Zebra
Gorlin syndrome (Gorlin Syndrome Alliance)
Antepartum care (first trimester): Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (third trimester): Clinical sciences
Fetal aneuploidy screening: Clinical sciences
Intrapartum care (1st, 2nd, 3rd, and 4th stages): Clinical sciences
Cystic fibrosis: Pathology review
Autosomal trisomies: Pathology review
Miscellaneous genetic disorders: Pathology review
Gastroschisis
Omphalocele
Approach to abdominal wall defects: Clinical sciences
Early pregnancy loss: Clinical sciences
Pyloric stenosis: Clinical sciences
Pyloric stenosis
Esophageal atresia and tracheoesophageal fistula: Year of the Zebra
Intestinal atresia
Hirschsprung disease
Hirschsprung disease: Year of the Zebra
Alagille syndrome (NORD)
Renal agenesis
Bladder exstrophy
Horseshoe kidney
Hypospadias and epispadias
Potter sequence
Posterior urethral valves
Renal tubular acidosis
Parathyroid disorders and calcium imbalance: Pathology review
Diabetes insipidus
Diabetes insipidus: Clinical sciences
Breast cancer: Pathology review
Breast cancer
Breast cancer screening: Clinical sciences
Colorectal polyps and cancer: Pathology review
Neuroendocrine tumors of the gastrointestinal system: Pathology review
Familial adenomatous polyposis
Multiple endocrine neoplasia: Clinical sciences
Fanconi anemia: Year of the Zebra 2025
Desmoid Tumor (NORD)
Multiple endocrine neoplasia
Oncogenes and tumor suppressor genes
Necrosis and apoptosis
Charcot-Marie-Tooth disease
Spinal muscular atrophy
Precocious puberty
Delayed puberty
5-alpha-reductase deficiency
Androgen insensitivity syndrome
Kallmann syndrome
Puberty and Tanner staging
Amenorrhea
Hydronephrosis
Beta-thalassemia: Year of the Zebra
Alpha-thalassemia
Beta-thalassemia
Von Willebrand disease
Protein S deficiency
Factor V Leiden
Protein C deficiency
Antithrombin III deficiency
Zellweger spectrum disorders (NORD)
Glycogen metabolism
Hemochromatosis: Clinical sciences
Lesch-Nyhan syndrome
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Adrenoleukodystrophy (NORD)
Alzheimer disease: Clinical sciences
Alzheimer disease

Transcript

Watch video only

A newborn was delivered two days ago at home without any complications. Today, he was brought in for examination. The baby has a fever and a distended abdomen that's rigid on palpation. The mother mentions her son started vomiting a green fluid and that he has yet to pass his first stool. She also says she didn’t have access to prenatal care throughout the pregnancy. An x-ray was performed, and it showed air-fluid levels and dilated bowel loops, along with a “soap bubble” appearance. A pilocarpine-induced sweat test was done which showed a Cl- level over 60.

Now, the newborn seems to have cystic fibrosis. But first, a little physiology. Normally, elements like ions and water come in and out of the cell through specific channels located on the cell’s membrane. A very high yield fact you need to know is that there’s this particular channel called “cystic fibrosis transmembrane conductance regulator” or the CFTR protein, which is an ATP-gated channel, meaning it works by using ATP for energy. It transports negatively charged Cl-. In cells that produce mucus, it secretes the ion out of the cell, and in cells of the sweat glands, it reabsorbs Cl- back into the cell. Now, normally, cells in mucus membranes pump out chloride ions into the thick mucus, which helps attract water and make it less viscous. This mucus will protect the lining of organs and tissues like the airways, digestive system, and reproductive system. For example, the mucus produced by the glands in the airways allows the tiny cilia to sweep back and forth. This sweeping motion helps move the mucus and the bacteria or foreign particles trapped in it, out of the airways. Additionally, the CFTR protein also regulates the function of other channels, such as those that transport positively charged sodium ions. Now, cystic fibrosis, or CF, is an autosomal recessive disorder where there’s a mutation in the CFTR gene, and it is considered to be the most common lethal genetic disease in the Caucasian population. Keep in mind that the defective gene is located on chromosome 7 and that the defect itself is usually represented by ∆F508, an abbreviation which indicates that there’s a deletion of three nucleotides that code for phenylalanine at amino acid position 508. Another thing to know is that the ∆F508 mutation results in impaired post-translational processing. This means that the protein will be misfolded and it will not be glycosylated, so it’ll be retained in the endoplasmic reticulum, where it is degraded instead of being released to the cell membrane.

Without the CFTR protein on the epithelial surface, cells can’t transport chloride ions. In the mucus-secreting cells, the defect prevents chloride from being secreted, which causes intracellular levels to increase. It also leads to a compensatory sodium reabsorption via the epithelial sodium channels, or ENaC, because the inhibitory effect of the CFTR protein on ENaC is missing. Interestingly, this increase in sodium reabsorption causes a negative transepithelial potential difference, which basically means the epithelial surfaces with mucus producing glands have a significantly more negative electrical charge. This is important because the negative transepithelial potential difference can be measured intranasally, and thus it can be used as a diagnosis test for CF. Ok so going back to chloride ions, a high yield concept is that because they are trapped inside the cell, water won’t be attracted to the mucus to thin it out. As a result, the mucus secreted by these cells will be abnormally thick, so it builds up and obstructs the organs where it is secreted, causing extensive damage. In parallel, in sweat-producing cells, the defect prevents chloride ions from being reabsorbed, thus it accumulates in the sweat.

Now, this leads to a wide range of signs and symptoms, which mostly depend on the individual’s age. In a newborn baby, the thick secretions can affect the baby’s meconium or first stool. The meconium can get so thick and sticky that it gets stuck in the baby’s intestines and can cause small bowel obstruction. This is called a meconium ileus, and it is considered a surgical emergency because the obstruction can lead to bowel perforation and peritonitis. On examination, babies initially present a distended and rigid abdomen, and they might look mottled and lethargic. Another sign of obstruction is bilious vomiting, which is when the vomit has a green color due to a high bile content. If bowel perforation occurs, it can lead to septic shock, which can ultimately cause organ failure and death. If a baby is septic, the vital signs might show temperature instability, either a fever or hypothermia, tachycardia, tachypnea, and hypotension. Something to keep in mind is if a newborn survives meconium ileus, without proper management, they will most likely die of cardiorespiratory complications like pneumonia or bronchiectasis, which account for more than 80% of deaths due to CF.

In early childhood, the most prominent and high yield complication of CF is pancreatic insufficiency. This happens because thick secretions block the pancreatic ducts, preventing digestive enzymes from making it into the small intestine. Without those pancreatic enzymes, fat isn’t absorbed, causing steatorrhea or an abnormal amount of fat in a person’s stools. Over time, this can lead to poor weight gain and failure to thrive because most of the nutrients and fat-soluble vitamins like vitamin A, D, E, and K, are lost through stool.

Something that you might encounter on your test is avitaminosis A, which is important since it leads to squamous metaplasia of the epithelial lining of pancreatic exocrine ducts. This is particularly problematic because there’s already pancreatic damage, usually from the backed-up digestive enzymes that will start digesting the pancreas, causing pancreatitis. Sometimes, the destruction of pancreatic tissue can also reduce the endocrine function of the pancreas, causing insulin-dependent diabetes mellitus.

As the child grows, their lungs can also be affected, usually because the mucus in their airways are so thick that the cilia can’t move them out. So they get repeatedly colonized by bacteria, which causes chronic bacterial infection and inflammation. Sometimes, the mucus can get compacted and it starts acting as a mucus plug, which alongside chronic bacterial infection and inflammation, leads to bronchiectasis. Bronchiectasis represents damage to the airway walls that causes permanent dilation of the bronchi. This causes respiratory symptoms like cough with lots of sputum, and if the damage extends to the blood vessels, it can lead to hemoptysis.

Individuals can also develop recurrent pneumonia, especially when there’s chronic lower respiratory infections. There are a couple of high yield bacteria you need to remember! In infants and children, the pneumonia-causing pathogens are often gram positive bacteria, like Staphylococcus aureus or methicillin-resistant Staphylococcus aureus, whereas in teens and adults, it’s usually gram negative bacteria, like Pseudomonas aeruginosa. The recurrence of Pseudomonas aeruginosa pneumonia in CF has been linked, in part, to the bacteria’s ability to form biofilms. Biofilms are defined as communities of microorganisms that are attached to a surface, and in Pseudomonas cases, this is possible due to its mucoid polysaccharide capsule which makes it sticky.

Another thing to look out for is and allergic bronchopulmonary aspergillosis, or ABPA, which is a hypersensitivity reaction to the fungus Aspergillus fumigatus that can live in the sinus or lung cavity. Sometimes pulmonary symptoms can increase rapidly, causing a CF exacerbation. This usually includes worsening productive cough with sputum, dyspnea with exertion, fatigue, decreased appetite, and fever. Over time, repeated cystic fibrosis exacerbations can lead to irreversible respiratory failure and death.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Fishman's Pulmonary Diseases and Disorders, 2-Volume Set, 5th edition" McGraw-Hill Education / Medical (2015)
  6. "Dyspnea" CRC Press (2014)
  7. "Toward inclusive therapy with CFTR modulators: Progress and challenges" Pediatric Pulmonology (2017)
  8. "Newborn Screening for Cystic Fibrosis: A Lesson in Public Health Disparities" The Journal of Pediatrics (2008)
  9. "Gastrointestinal Disorders in Cystic Fibrosis" Clinics in Chest Medicine (2016)